Efficacy and safety of established and off‐label ADHD drug therapies for cognitive impairment or attention‐deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force.

Saved in:
Bibliographic Details
Title: Efficacy and safety of established and off‐label ADHD drug therapies for cognitive impairment or attention‐deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force.
Authors: Miskowiak, Kamilla W.1,2 (AUTHOR) kamilla.miskowiak@regionh.dk, Obel, Zacharias K.1,2 (AUTHOR), Guglielmo, Riccardo3,4 (AUTHOR), Bonnin, Caterina del Mar5 (AUTHOR), Bowie, Christopher R.6 (AUTHOR), Balanzá‐Martínez, Vicent7 (AUTHOR), Burdick, Katherine E.8,9 (AUTHOR), Carvalho, Andre F.10 (AUTHOR), Dols, Annemieke11 (AUTHOR), Douglas, Katie12 (AUTHOR), Gallagher, Peter13 (AUTHOR), Kessing, Lars V.2,14 (AUTHOR), Lafer, Beny15 (AUTHOR), Lewandowski, Kathryn E.8,16 (AUTHOR), López‐Jaramillo, Carlos17 (AUTHOR), Martinez‐Aran, Anabel5 (AUTHOR), McIntyre, Roger S.18 (AUTHOR), Porter, Richard J.12 (AUTHOR), Purdon, Scot E.19 (AUTHOR), Schaffer, Ayal20 (AUTHOR)
Source: Bipolar Disorders. May2024, Vol. 26 Issue 3, p216-239. 24p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13985647
DOI:10.1111/bdi.13414